搜索

021-65675885

化合物库

Custom Compound Library (zk012)

 

A custom library of 113 anti-cancer compounds, covering kinase inhibitors, as well as  approved, preclinical and clinical-stage drugs. Suitable for positive-control tests and cross-cancer correlation studies, this collection comprises agents with confirmed or potential anti-tumor activity, with a particular focus on kinase-targeting agents. Numerous cancer types are driven by aberrant activation of specific kinases, molecules target abnormally activated kinases that control cell proliferation, apoptosis and angiogenesis, showing promising performance in pre-clinical and early-clinical research.

 


查看其他分子库

在线客服>>

在线留言x
  • 类型 * :
  • 姓名 * :
  • 电子邮件 * :
  • 手机号码 * :
  • 单位名称 * :
  • 在线留言 * :